BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 8211161)

  • 1. Structural features of polysaccharides that induce intra-abdominal abscesses.
    Tzianabos AO; Onderdonk AB; Rosner B; Cisneros RL; Kasper DL
    Science; 1993 Oct; 262(5132):416-9. PubMed ID: 8211161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial structure and functional relation to abscess formation.
    Tzianabos AO; Onderdonk AB; Kasper DL
    Infect Agents Dis; 1994 Oct; 3(5):256-65. PubMed ID: 7866658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and function of Bacteroides fragilis capsular polysaccharides: relationship to induction and prevention of abscesses.
    Tzianabos AO; Kasper DL; Onderdonk AB
    Clin Infect Dis; 1995 Jun; 20 Suppl 2():S132-40. PubMed ID: 7548535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural characteristics of polysaccharides that induce protection against intra-abdominal abscess formation.
    Tzianabos AO; Onderdonk AB; Zaleznik DF; Smith RS; Kasper DL
    Infect Immun; 1994 Nov; 62(11):4881-6. PubMed ID: 7927768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-function relationships for polysaccharide-induced intra-abdominal abscesses.
    Tzianabos AO; Onderdonk AB; Smith RS; Kasper DL
    Infect Immun; 1994 Aug; 62(8):3590-3. PubMed ID: 8039936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunochemical and biological characterization of three capsular polysaccharides from a single Bacteroides fragilis strain.
    Kalka-Moll WM; Wang Y; Comstock LE; Gonzalez SE; Tzianabos AO; Kasper DL
    Infect Immun; 2001 Apr; 69(4):2339-44. PubMed ID: 11254591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenicity of Bacteroides fragilis group in rat intra-abdominal abscesses.
    Jotwani R; Gupta U; Watanabe K; Ueno K
    Microbiol Immunol; 1992; 36(10):1041-9. PubMed ID: 1479960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inducing an abscess.
    Cross AS
    Lancet; 1994 Jan; 343(8892):248-9. PubMed ID: 7905090
    [No Abstract]   [Full Text] [Related]  

  • 9. Analysis of a capsular polysaccharide biosynthesis locus of Bacteroides fragilis.
    Comstock LE; Coyne MJ; Tzianabos AO; Pantosti A; Onderdonk AB; Kasper DL
    Infect Immun; 1999 Jul; 67(7):3525-32. PubMed ID: 10377135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental intraabdominal abscess formation by Escherichia coli and bacteroides fragilis.
    Hagen JC; Wood WS; Hashimoto T
    Eur J Clin Microbiol; 1983 Feb; 2(1):43-9. PubMed ID: 6341050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virulence factors in Bacteroides fragilis group.
    Jotwani R; Gupta U
    Indian J Med Res; 1991 Jul; 93():232-5. PubMed ID: 1959952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infection with Bacteroides fragilis: pathogenesis and immunoprophylaxis in an animal model.
    Kasper DL; Onderdonk AB
    Scand J Infect Dis Suppl; 1982; 31():28-33. PubMed ID: 6954635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification of Capsular Polysaccharide Complex from Gram-Negative Bacteria.
    Alvarez CA; Cobb BA
    Methods Mol Biol; 2019; 1954():25-35. PubMed ID: 30864121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenicity of piliated and encapsulated Bacteroides fragilis.
    Brook I; Coolbaugh JC; Walker RI
    Eur J Clin Microbiol; 1984 Jun; 3(3):207-9. PubMed ID: 6147247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a model of intraabdominal sepsis for studies of the pathogenicity of Bacteroides fragilis.
    Onderdonk AB; Shapiro ME; Finberg RW; Zaleznik DF; Kasper DL
    Rev Infect Dis; 1984; 6 Suppl 1():S91-5. PubMed ID: 6372042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polysaccharide-mediated protection against abscess formation in experimental intra-abdominal sepsis.
    Tzianabos AO; Kasper DL; Cisneros RL; Smith RS; Onderdonk AB
    J Clin Invest; 1995 Dec; 96(6):2727-31. PubMed ID: 8675640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of molecular size on the ability of zwitterionic polysaccharides to stimulate cellular immunity.
    Kalka-Moll WM; Tzianabos AO; Wang Y; Carey VJ; Finberg RW; Onderdonk AB; Kasper DL
    J Immunol; 2000 Jan; 164(2):719-24. PubMed ID: 10623815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural elucidation of the capsular polysaccharide of Bacteroides fragilis strain 23745M1.
    Pavliak V; UhrĂ­n D; Brisson JR; Tzianabos AO; Kasper DL; Jennings HJ
    Carbohydr Res; 1995 Oct; 275(2):333-41. PubMed ID: 8529227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The capsular polysaccharide of Bacteroides fragilis as a virulence factor: comparison of the pathogenic potential of encapsulated and unencapsulated strains.
    Onderdonk AB; Kasper DL; Cisneros RL; Bartlett JG
    J Infect Dis; 1977 Jul; 136(1):82-9. PubMed ID: 886206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orientations of the Bacteroides fragilis capsular polysaccharide biosynthesis locus promoters during symbiosis and infection.
    Troy EB; Carey VJ; Kasper DL; Comstock LE
    J Bacteriol; 2010 Nov; 192(21):5832-6. PubMed ID: 20729352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.